Predictive and prognostic markers are at the forefront of personalised cancer care, offering clinicians the ability to both anticipate a patient’s response to specific therapies and gauge the likely ...
Investigators at Massachusetts General Hospital in Boston conducted an analysis of the fusion oncogene EML4-ALK and the more well-studied epidermal growth factor receptor (EGFR) mutation among a group ...
Furthermore, lipoprotein (a), a protein that lives in the wall surrounding cholesterol particles, is another marker that can ...